Triple Agonist
GLP-3 20 MG
A triple receptor agonist peptide investigated in research on incretin and metabolic signaling pathways.
Choose a size
Research Use Only · No Medical Advice
Products are for in-vitro laboratory research only and are not for human or animal consumption. Information on this site is educational, is not medical advice, and has not been evaluated by the FDA.
Certificate of Analysis
- Purity (HPLC)
- 99.99%
- Lot number
- TP260620
- Tested
- 2026-07-29
- Formula
- C221H342N46O68
- Verified by
- Accumark Labs
Full lot reports are available on request — send the lot number printed on your vial and we email you the report.
Research focus areas
- GLP-1, GIP and glucagon receptor signaling research
- Incretin pathway studies
- Metabolic syndrome research models
For research use only. Not for human or animal consumption. Not a drug, food, or cosmetic.
What researchers are studying
Retatrutide is studied in published clinical and preclinical research as a triple GLP-1/GIP/glucagon receptor agonist in metabolic signaling models.
Browse published studies on PubMedFor research use only. Not for human or animal consumption. Not a drug, food, or cosmetic.